PureTech Health (PRTC) Other Non-Current Liabilities (2020 - 2025)
PureTech Health (PRTC) reported Other Non-Current Liabilities of $1.2 million for Q4 2025, down 34.61% year-over-year from $1.9 million in Q4 2024, and up 42.84% quarter-over-quarter from $852000.0 in Q2 2025.
PureTech Health (PRTC) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends
PureTech Health (PRTC) has 6 years of Other Non-Current Liabilities data on file, last reported at $1.2 million in Q4 2025.
- Other Non-Current Liabilities for Q4 2025 came in at $1.2 million, down 34.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.2 million (down 34.61% YoY), and the FY2025 annual result was $1.2 million, down 34.61% from the prior year.
- Other Non-Current Liabilities advanced to $1.2 million in Q4 2025 per PRTC's latest filing, from $852000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $16.9 million in Q4 2021 and troughed at $852000.0 in Q2 2025.
- A 5-year average of $6.5 million and a median of $2.7 million in 2023 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2021 and 2023: Other Non-Current Liabilities grew 14.19% in 2021, then sank 75.64% in 2023.
- A 5-year view of Other Non-Current Liabilities shows it stood at $16.9 million in 2021, then retreated by 15.06% to $14.4 million in 2022, then slumped by 75.64% to $3.5 million in 2023, then tumbled by 46.84% to $1.9 million in 2024, then plunged by 34.61% to $1.2 million in 2025.
- Business Quant data shows PRTC's Other Non-Current Liabilities at $1.2 million in Q4 2025, $852000.0 in Q2 2025, and $1.9 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.22 Mn |
| Jun 30, 2025 | 852,000.00 |
| Dec 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Dec 31, 2022 | 14.37 Mn |
| Dec 31, 2021 | 16.92 Mn |
| Dec 31, 2020 | 14.82 Mn |